[HTML] frontiersin.org

[HTML][HTML] The role of trabectedin in soft tissue sarcoma

T Nakamura, A Sudo - Frontiers in Pharmacology, 2022 - frontiersin.org
Background: Systemic chemotherapy for advanced disease is another therapeutic option in
the management of metastases in soft tissue sarcoma (STS). Doxorubicin either alone or in …
被引用次数：16 相关文章
[HTML] nih.gov

[HTML][HTML] The Role of Trabectedin in Soft Tissue Sarcoma

T Nakamura, A Sudo - Frontiers in Pharmacology, 2022 - ncbi.nlm.nih.gov
Background: Systemic chemotherapy for advanced disease is another therapeutic option in
the management of metastases in soft tissue sarcoma (STS). Doxorubicin either alone or in …

The Role of Trabectedin in Soft Tissue Sarcoma

T Nakamura, A Sudo - … Alkaloids on Solid Cancer: Mechanisms of …, 2023 - books.google.com
Background: Systemic chemotherapy for advanced disease is another therapeutic option in
the management of metastases in soft tissue sarcoma (STS). Doxorubicin either alone or in …

The Role of Trabectedin in Soft Tissue Sarcoma

T Nakamura, A Sudo - Frontiers in pharmacology, 2022 - pubmed.ncbi.nlm.nih.gov
Background: Systemic chemotherapy for advanced disease is another therapeutic option in
the management of metastases in soft tissue sarcoma (STS). Doxorubicin either alone or in …

The Role of Trabectedin in Soft Tissue Sarcoma.

T Nakamura, A Sudo - Frontiers in Pharmacology, 2022 - europepmc.org
Background: Systemic chemotherapy for advanced disease is another therapeutic option in
the management of metastases in soft tissue sarcoma (STS). Doxorubicin either alone or in …

The Role of Trabectedin in Soft Tissue Sarcoma.

T Nakamura, A Sudo - Frontiers in Pharmacology, 2022 - europepmc.org
Background: Systemic chemotherapy for advanced disease is another therapeutic option in
the management of metastases in soft tissue sarcoma (STS). Doxorubicin either alone or in …